Matthew B. Boxer

Dr. Matthew Boxer has more than 10 years of drug discovery, research and development experience following a career at the NIH, most recently at NCATS, where he was Medicinal Chemistry Group Leader. At NCATS, he led interdisciplinary teams responsible for small molecule hit-to-lead and lead-optimization for over 25 projects across a wide range of indications, with a large focus on rare diseases. Recently, Dr. Boxer was project lead on a multi-institutional drug discovery project that delivered a clinical product candidate for advancement to investigational new drug (IND)-enabling studies. Dr. Boxer has managed collaborations with more than 30 external investigators from academia, NIH, and the biotechnology sector in the US and abroad. He is an inventor on 13 patents, with multiple patents licensed by biotechnology companies. Dr. Boxer earned a Bachelor of Science in Chemistry from the University of Vermont and a PhD in Chemistry from the University of Chicago. He received postdoctoral training at the NIH within the division of preclinical innovation. Dr. Boxer currently reviews for several journals, grant organizations, government and foundations with a focus on drug discovery.